Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (111-120 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 4, 2008
Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liverMarco H Hofmann, Julia K Blievernicht, Kathrin Klein, et al.
Pharmacogenetics|March 25, 1998
Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German populationE U Griese, U M Zanger, U Brudermanns, et al.
Genome Medicine|January 15, 2013
Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1Anne T Nies, Mikko Niemi, Oliver Burk, et al.
The Histochemical Journal|January 5, 2002
Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumoursJ K Coller, P Fritz, U M Zanger, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjectsSebastian Raimundo, Claudia Toscano, Kathrin Klein, et al.
Pharmacogenomics|May 1, 2007
Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomesMarkus Schirmer, Albert Rosenberger, Kathrin Klein, et al.
Biochimica Et Biophysica Acta|March 21, 2016
Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytesBenjamin A Kandel, Maria Thomas, Stefan Winter, et al.
Hepatology (Baltimore, Md.)|September 27, 2003
Sex is a major determinant of CYP3A4 expression in human liverRenzo Wolbold, Kathrin Klein, Oliver Burk, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2003
Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidineTanja Richter, Thomas E Mürdter, Georg Heinkele, et al.
Pharmacogenetics|September 30, 2003
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6Julia Kirchheiner, Christian Klein, Ingolf Meineke, et al.
Pageof 21

Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Pharmacology and Experimental Therapeutics|January 4, 2008
Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liverMarco H Hofmann, Julia K Blievernicht, Kathrin Klein, et al.
Pharmacogenetics|March 25, 1998
Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German populationE U Griese, U M Zanger, U Brudermanns, et al.
Genome Medicine|January 15, 2013
Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1Anne T Nies, Mikko Niemi, Oliver Burk, et al.
The Histochemical Journal|January 5, 2002
Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumoursJ K Coller, P Fritz, U M Zanger, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjectsSebastian Raimundo, Claudia Toscano, Kathrin Klein, et al.
Pharmacogenomics|May 1, 2007
Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomesMarkus Schirmer, Albert Rosenberger, Kathrin Klein, et al.
Biochimica Et Biophysica Acta|March 21, 2016
Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytesBenjamin A Kandel, Maria Thomas, Stefan Winter, et al.
Hepatology (Baltimore, Md.)|September 27, 2003
Sex is a major determinant of CYP3A4 expression in human liverRenzo Wolbold, Kathrin Klein, Oliver Burk, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2003
Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidineTanja Richter, Thomas E Mürdter, Georg Heinkele, et al.
Pharmacogenetics|September 30, 2003
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6Julia Kirchheiner, Christian Klein, Ingolf Meineke, et al.
Pageof 21